This protocol integrates experimental methods and R scripts to assess mutation rates in heterochromatin, suggesting new insights into epigenetics.
Understanding how chromatin organization influences mutation rates is fundamental for advancing epigenetics, genome stability studies, and therapeutic development. H3K9-methylated heterochromatin has been implicated in elevated mutation rates, yet precise estimation under controlled conditions remains challenging due to both experimental and analytical limitations. This protocol provides an integrated experimental and computational framework to investigate the effect of H3K9-methylated heterochromatin on spontaneous mutation rates in Schizosaccharomyces pombe. We utilize a tetracycline-inducible system that switches a reporter gene, ura4, between euchromatic and heterochromatic states within a single isogenic clone during one experiment. Mutation rates are estimated using a precision-enhanced 96-well fluctuation assay, which improves reproducibility and minimizes variability by enabling side-by-side comparison of chromatin states. For data analysis, we developed a new R script that requires only two inputs—mutant counts (r) and total cell numbers (Nt)—and implements a non-recursive Ma–Sandri–Sarkar maximum likelihood estimator (MSS-MLE) with bootstrap-derived confidence intervals, optimized for large datasets. The script outputs: (i) two-parameter model estimates (m and d); (ii) MSS-MLE estimate of m with 95% confidence intervals by normal approximation and bootstrap; (iii) mutation rate (μ) with 95% confidence intervals; and (iv) cumulative distribution function plots comparing empirical data with theoretical model predictions.This methodology enables rigorous estimation of heterochromatin dependent mutation rates with reduced technical bias. Expected results demonstrate quantifiable mutation rate differences between H3K9-methylated heterochromatin and euchromatin states. By integrating controlled chromatin state switching, fluctuation assays, and robust R based statistical tools, the method addresses limitations of traditional mutation rate studies and provides an accurate technique for investigating epigenetic influences on genome stability, with applications in cancer research, evolutionary genetics, and epigenetic therapy development.
No takes yet. Share an insight, caveat, or question.
Abdalla et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: